More than 15 million Americans have some form of eczema, a skin condition characterized by itchy, red patches that can crack and ooze. Imbalances in the immune system can trigger an eczema flare-up through the release of chemical mediators such as interleukins -4 and -13 (IL-4 and IL-13).
Aeroderm™ targets the root cause of eczema by interupting the immune response to allergens in eczematous skin by blocking the pro-inflammatory effects of IL-4 and IL-13 through inhibition of IL4Ra receptor and downstream immune system responses.
If you want to learn more about atopic eczema, please consult your physician or the following resources:
The Eczema Resource: http://www.eczemaresource.com/eczema/eczema.asp
The American Academy of Dermatology: http://www.aad.org/default.htm
